Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that the Agenzia Italiana del Farmaco (AIFA) has approved a new Phase 1 ...

plus Nivolumab and CAPOX as the first-line treatment for the patients with advanced G/GEJ cancer (TranStar102). The updated data continues to show encouraging efficacy from previously disclosed data ...

Tom Parker Bowles, the stepson of King Charles III, recently opened up about his stepfather's battle with cancer, referring to the illness as "a b*****." Despite the challenges that come with ...

Espanyol manager Manolo González has backed Tottenham youngster Alejo Véliz for a bright future, despite something of a rough introduction to life in La Liga. Mundo Deportivo cover comments from ...

Design: Retrospective study. Methods: Data from patients with consistent access to the Parkinson’s and Movement Disorder Center of L’Aquila over the last 10-year period were screened. Patients ...

Now, working with lung cancer patients, she can tell them she went through something similar and offer words of encouragement about the doctors who not only work with her but also treated her.

plus Nivolumab and CAPOX as the first-line treatment for the patients with advanced G/GEJ cancer (TranStar102). The updated data continues to show encouraging efficacy from previously disclosed ...

plus Nivolumab and CAPOX as the first-line treatment for the patients with advanced G/GEJ cancer (TranStar102). The updated data continues to show encouraging efficacy from previously disclosed data ...

"These findings are encouraging and demonstrate that Commission on Cancer accreditation increases compliance with guideline-based care and improves outcomes for cancer patients. This work shows ...